Acne - best practice management.
BACKGROUND
Acne vulgaris can have a substantial impact on a patient's quality of life; there can be significant psychosocial consequences and it can leave permanent physical scarring. Early and effective acne treatment is important.


OBJECTIVE
To describe the outcome of an accredited clinical audit investigating general practitioner management of acne vulgaris and to provide an outline of current 'best practice' acne management.


CONCLUSIONS
The audit was conducted over two cycles with GPs receiving educational material between cycles. Eighty-five GPs contributed data on 1638 patients. General practitioner management of acne was assessed against a set of preset standards and some acne treatment was found to be inconsistent with best practice, particularly for patients with moderate and moderate to severe acne, where many patients were either being undertreated or treatment with antibiotic therapy was suboptimal. It is likely that this treatment gap is overestimated due to practical limitations of the audit process; however, the audit revealed a need to address the main sources of apparent divergence from best practice to improve the quality use of acne therapies.
Cook
David
D
Department of Dermatology, Concord Hospital, Sydney, New South Wales. dkcook@bigpond.net.au
Krassas
George
G
Huang
Tom
T
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000523:psychology; D000465:Algorithms; D001315:Australia; D019985:Benchmarking; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004502:Education, Medical, Continuing; D005260:Female; D058005:General Practitioners; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D008297:Male; D011446:Prospective Studies; D011787:Quality of Health Care; D012176:Retinoids / Q000627:therapeutic use*; D020156:Salicylic Acid / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D003879:Dermatologic Agents; D012176:Retinoids; D015474:Isotretinoin; D020156:Salicylic Acid